Literature DB >> 19390346

Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction.

Ari Cedars1, Christopher M Jenkins, David J Mancuso, Richard W Gross.   

Abstract

Myocardial function is intimately dependent on the precise spatiotemporal regulation of membrane-bound proteins and ion channels. Phospholipases play critical roles in the maintenance of membrane structure and function, thereby fundamentally integrating dynamic alterations in myocardial performance with membrane composition and dynamics. The major phospholipases in myocardium belong to a family of proteins known as calcium-independent phospholipases (iPLA2s). In addition to their role in maintaining normal membrane structure and function, iPLA2 catalytic activity results in the generation of a variety of lipid second messengers that facilitate cellular signaling. Through its multiple effects on cardiac myocyte bioenergetics, cellular signaling, and membrane function, the iPLA2 family of enzymes is of primary importance in modulating the pathologic sequelae of myocardial ischemia, diabetic cardiomyopathy, and remodeling during hemodynamic stress. This review will provide a brief overview of myocardial iPLA2s and their significance in cardiac pathology and physiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19390346      PMCID: PMC2684941     

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  110 in total

1.  Irreversible inhibition of Ca(2+)-independent phospholipase A2 by methyl arachidonyl fluorophosphonate.

Authors:  Y C Lio; L J Reynolds; J Balsinde; E A Dennis
Journal:  Biochim Biophys Acta       Date:  1996-07-12

Review 2.  Cytosolic phospholipase A2.

Authors:  J D Clark; A R Schievella; E A Nalefski; L L Lin
Journal:  J Lipid Mediat Cell Signal       Date:  1995-10

3.  The calcium-dependent association and functional coupling of calmodulin with myocardial phospholipase A2. Implications for cardiac cycle-dependent alterations in phospholipolysis.

Authors:  M J Wolf; R W Gross
Journal:  J Biol Chem       Date:  1996-08-30       Impact factor: 5.157

4.  Identification of essential residues for the catalytic function of 85-kDa cytosolic phospholipase A2. Probing the role of histidine, aspartic acid, cysteine, and arginine.

Authors:  R T Pickard; X G Chiou; B A Strifler; M R DeFelippis; P A Hyslop; A L Tebbe; Y K Yee; L J Reynolds; E A Dennis; R M Kramer; J D Sharp
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

5.  Depletion of intracellular calcium stores activates smooth muscle cell calcium-independent phospholipase A2. A novel mechanism underlying arachidonic acid mobilization.

Authors:  M J Wolf; J Wang; J Turk; R W Gross
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

6.  Expression, purification, and kinetic characterization of a recombinant 80-kDa intracellular calcium-independent phospholipase A2.

Authors:  M J Wolf; R W Gross
Journal:  J Biol Chem       Date:  1996-11-29       Impact factor: 5.157

7.  2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells.

Authors:  T Sugiura; T Kodaka; S Kondo; T Tonegawa; S Nakane; S Kishimoto; A Yamashita; K Waku
Journal:  Biochem Biophys Res Commun       Date:  1996-12-04       Impact factor: 3.575

8.  A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs.

Authors:  J Tang; R W Kriz; N Wolfman; M Shaffer; J Seehra; S S Jones
Journal:  J Biol Chem       Date:  1997-03-28       Impact factor: 5.157

9.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.

Authors:  T Sugiura; S Kondo; A Sukagawa; S Nakane; A Shinoda; K Itoh; A Yamashita; K Waku
Journal:  Biochem Biophys Res Commun       Date:  1995-10-04       Impact factor: 3.575

10.  Glyburide-reversible cardioprotective effects of calcium-independent phospholipase A2 inhibition in ischemic rat hearts.

Authors:  C A Sargent; M W Wilde; S Dzwonczyk; J G Tuttle; H N Murray; K Atwal; G J Grover
Journal:  Cardiovasc Res       Date:  1996-02       Impact factor: 10.787

View more
  26 in total

1.  Endothelial cell prostaglandin I(2) and platelet-activating factor production are markedly attenuated in the calcium-independent phospholipase A(2)beta knockout mouse.

Authors:  Janhavi Sharma; John Turk; Jane McHowat
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

2.  Urothelial cell platelet-activating factor production mediated by calcium-independent phospholipase A2γ.

Authors:  Prerna Rastogi; Alice Rickard; David J Klumpp; Jane McHowat
Journal:  Urology       Date:  2010-11-20       Impact factor: 2.649

Review 3.  Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.

Authors:  Edward A Dennis; Jian Cao; Yuan-Hao Hsu; Victoria Magrioti; George Kokotos
Journal:  Chem Rev       Date:  2011-09-12       Impact factor: 60.622

4.  Platelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung.

Authors:  Jane McHowat; Gail Gullickson; Richard G Hoover; Janhavi Sharma; John Turk; Jacki Kornbluth
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-12       Impact factor: 4.249

5.  Cyclooxygenase-2 Mediated Oxidation of 2-Arachidonoyl-Lysophospholipids Identifies Unknown Lipid Signaling Pathways.

Authors:  Xinping Liu; Sung Ho Moon; Christopher M Jenkins; Harold F Sims; Richard W Gross
Journal:  Cell Chem Biol       Date:  2016-09-15       Impact factor: 8.116

Review 6.  Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.

Authors:  Ponugoti Vasantha Rao
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-27       Impact factor: 2.671

7.  Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.

Authors:  Tomohiro Kimura; Atsuko K Kimura; Mindong Ren; Bob Berno; Yang Xu; Michael Schlame; Richard M Epand
Journal:  Biochemistry       Date:  2018-03-30       Impact factor: 3.162

8.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

9.  Paraoxon attenuates vascular smooth muscle contraction through inhibiting Ca2+ influx in the rabbit thoracic aorta.

Authors:  Shouhong Zhou; Liying Liu; Xuhong Yang; Shujin Wu; Gengrong Chen
Journal:  J Biomed Biotechnol       Date:  2010-04-22

Review 10.  Lipidomics for studying metabolism.

Authors:  Xianlin Han
Journal:  Nat Rev Endocrinol       Date:  2016-07-29       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.